当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 利润表

康泰医学

(300869)

  

流通市值:32.66亿  总市值:320.07亿
流通股本:4100.00万   总股本:4.02亿

利润表

按照会计年度查询:
报告期2021-03-312020-12-312020-09-302020-06-30
一、营业总收入260,008,877.551,401,225,344.221,111,148,094.72751,089,637.92
营业收入260,008,877.551,401,225,344.221,111,148,094.72751,089,637.92
二、营业总成本133,523,891.7719,187,000.19534,314,009.3339,433,588.62
营业成本124,301,033.57585,024,896.01419,659,219.11262,579,149.97
营业税金及附加2,539,965.827,604,283.65,361,952.094,135,245.27
销售费用11,772,639.1861,161,981.3360,232,689.7545,726,885.76
管理费用7,772,295.4933,645,167.1425,251,503.3814,672,561.25
财务费用-26,894,103.03-16,986,493.44-9,054,175.06-9,828,844.38
资产减值损失-669,518.48-3,758,373.91-3,312,990.32-2,343,589.97
三、其他经营收益284,169.29-1,804,556.51-682,664.53333,213.91
允许价值变动净收益--------
投资净收益426,712.33167,808.220--
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润130,618,819.18714,635,983.83603,652,476.41428,774,916.86
营业外收入2,584.112,064,243.072,051,779.548,689.48
营业外支出464,602.631,228,947.951,377,852.81263,024.01
非流动资产处置净损失--------
五、利润总额130,156,800.66715,471,278.95604,326,403.1428,560,582.33
所得税15,343,361.76102,075,898.589,382,749.9464,823,438.52
未确认的投资损失--------
六、净利润(百万元)114.81613.4514.94363.74
少数股东损益--------
归属于母公司股东的净利润114,813,438.9613,395,380.45514,943,653.16363,737,143.81
七、每股收益0.291.641.411.01
基本每股收益0.291.641.411.01
稀释每股收益0.291.641.41--
TOP↑